Zobrazeno 31 - 40
of 262
pro vyhledávání: '"Kathleen A. Cooney"'
Publikováno v:
The Urologic clinics of North America. 48(3)
The identification and characterization of alterations in prostate cancer (PCa)-predisposing genes can help to inform screening strategies in undiagnosed men and treatment options in men in both the clinically localized and in the metastatic setting.
Autor:
Adam Bolton, Ann G. Schwartz, Julie J. Ruterbusch, Kendra Schwartz, Jennifer L. Beebe-Dimmer, Elisabeth I. Heath, Kathleen A. Cooney
Publikováno v:
Cancer Medicine, Vol 8, Iss 6, Pp 3325-3335 (2019)
Cancer Medicine
Cancer Medicine
Purpose Approximately 5% of men were initially diagnosed with (also referred to as de novo) advanced stage prostate cancer and experience far poorer survival compared to men diagnosed with local or regionally advanced disease. Given the number of new
Autor:
Ethan M Lange, Anna M Johnson, Yunfei Wang, Kimberly A Zuhlke, Yurong Lu, Jessica V Ribado, Gregory R Keele, Jin Li, Qing Duan, Ge Li, Zhengrong Gao, Yun Li, Jianfeng Xu, William B Isaacs, Siqun Zheng, Kathleen A Cooney
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e93436 (2014)
Prostate cancer is the most common non-skin cancer and the second leading cause of cancer related mortality for men in the United States. There is strong empirical and epidemiological evidence supporting a stronger role of genetics in early-onset pro
Externí odkaz:
https://doaj.org/article/98d573dd13d54d61b2bd7817179e867d
Autor:
Ashley L. Kapron, Christopher Martin, Michael Flynn, Brock O'Neil, Kathleen A. Cooney, Kensaku Kawamoto
Publikováno v:
Cancer Epidemiology. 56:112-117
Reports of low-value prostate-specific antigen (PSA) testing (testing in which the harms outweigh the benefits) generally employ population level data sources. While such results may be generalizable, they often lack the detail necessary to understan
Autor:
Robert Pilarski, Arthur L. Burnett, Lucia R. Languino, Colette Hyatt, Jacqueline Powers, Robert B. Den, Alberto Briganti, Veda N. Giri, Lorelei A. Mucci, Daniel P. Petrylak, Oliver Sartor, Amie Blanco, Daniel W. Lin, Himisha Beltran, E. David Crawford, Karen E. Knudsen, Mary-Ellen Taplin, Brian T. Helfand, Felix Y. Feng, Costas D. Lallas, E. Michael D. Scott, Wayne H. Pinover, R. Jeffrey Karnes, Scott Weissman, Evan Y. Yu, Timothy R. Rebbeck, Ashley H. Woodson, Matthew J. Schiewer, Todd M. Morgan, William B. Isaacs, Jeffrey N. Weitzel, Alanna Kulchak Rahm, Michael S. Cookson, James A. Eastham, S. Bruce Malkowicz, Neha Vapiwala, Kevin R. Loughlin, Raoul S. Concepcion, Ana Maria Lopez, Jose Moreno, Brock O'Neil, Patrick T. Gomella, Patrick Mille, Charnita Zeigler-Johnson, Howard M. Sandler, Kathleen A. Cooney, William Tester, Sarah M. Nielsen, Thomas J. Polascik, Richard C. Wender, Howard R. Soule, Ronald E. Myers, Scott E. Eggener, Marc B. Garnick, Stacy Loeb, Martin Miner, Anthony J. Costello, Gerald L. Andriole, Amanda E. Toland, David Y.T. Chen, Albert Dobi, Joseph K Izes, Mary B. Daly, Leonard G. Gomella, Mark D. Hurwitz, J. Kellogg Parsons, Matthew L. Freedman, Nathan Handley, Adam P. Dicker, Jianfeng Xu, Michael Russell Mullane, Charles J. Ryan, Edouard J. Trabulsi, Anne Calvaresi, James Ryan Mark, Thenappan Chandrasekar, Colin C. Pritchard, Saud H. AlDubayan, Curtis A. Pettaway, William Kevin Kelly, Lindsey Byrne, Peter R. Carroll, Brittany M. Szymaniak, Alicia K. Morgans, Peter A. Pinto, William L. Dahut, Mark Mann, Ganesh V. Raj, James L. Mohler, Wendy Poage, Heather H. Cheng, Grace L. Lu-Yao
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 38, iss 24
PURPOSE Germline testing (GT) is a central feature of prostate cancer (PCA) treatment, management, and hereditary cancer assessment. Critical needs include optimized multigene testing strategies that incorporate evolving genetic data, consistency in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1a0090e4e87cd120ef0899e6263c77c
https://escholarship.org/uc/item/3mg229rb
https://escholarship.org/uc/item/3mg229rb
Autor:
S. Lilly Zheng, David Duggan, Richard J. Fantus, Brian T. Helfand, William B. Isaacs, Rong Na, Chi Hsiung Wang, Kathleen A. Cooney, Scott E. Eggener, Elizabeth A. Platz, Jun Wei, Zhuqing Shi, Peter J. Hulick, Jianfeng Xu
Publikováno v:
European urology. 79(3)
Single nucleotide polymorphism-based genetic risk score (GRS) has been developed and validated for prostate cancer (PCa) risk assessment. As GRS is population standardized, its value can be interpreted as a relative risk to the general population.To
Publikováno v:
Handbook of Tumor Syndromes ISBN: 9781351187435
Handbook of Tumor Syndromes
Handbook of Tumor Syndromes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68f87f2886c79b50220beca3cae90d05
https://doi.org/10.1201/9781351187435-33
https://doi.org/10.1201/9781351187435-33
Autor:
Marta Gielzak, Patrick C. Walsh, Kathleen E. Wiley, Shuwei Li, Brice A. J. Sarver, Hongjie Yu, Tamara L. Lotan, Rong Na, Mary Helen Black, Brian T. Helfand, Yishuo Wu, William B. Isaacs, Siqun Zheng, Kathleen A. Cooney, Jianfeng Xu, Holly LaDuca
Publikováno v:
Journal of Urology. 203
Autor:
Jianfeng Xu, Richard J Fantus, Brian T. Helfand, Kathleen A. Cooney, Siqun Zheng, Yishuo Wu, Zhuqing Shi, William B. Isaacs, Jun Wei
Publikováno v:
Journal of Urology. 203
Autor:
Bing Jian Feng, Kathleen A. Cooney, Samantha Greenberg, Lisa A. Cannon-Albright, Timothy J. Parnell, Ashley L. Kapron, Neeraj Agarwal, Craig C. Teerlink, Benjamin L. Maughan, Andrew W. Hahn, Wendy Kohlmann, Julie L Boyle
Publikováno v:
JCO Precis Oncol
PURPOSE Germline mutations in DNA repair (DR) genes and susceptibility genes CDKN2A and HOXB13 have previously been associated with prostate cancer (PC) incidence and/or progression. However, the role and prevalence of this class of mutations in meta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bae2dfbf317f2c47388511e770a99a8e
https://europepmc.org/articles/PMC7446531/
https://europepmc.org/articles/PMC7446531/